Cotidié's fabrics are lightweight and moisture wicking — similar to exercise clothing — making the pieces conducive to the Houston heat and humidity. Lauren Marek/Cotidié

Houston is a humid subtropical climate — the majority of the year brings hot and sticky weather. Local entrepreneur Kristina Haag found herself struggling to find traditional clothing that is comfortable in the Texas heat, so she created it herself.

"With Cotidié, it is all about the functionality of the clothing," says Haag, founder of the clothing line Cotidié. "It is more traditional items, but the use of technical fabrics is our differentiating factor."

The online retailer, which launched in June 2019, offers pieces specifically tailored for women who are up against Houston's hot and muggy climate.

The line offers dresses, jackets, pants, skirts, and tops, ranging between $60 and $200 in price. The fabrics, sourced from Italy and Taiwan, provide breathable comfort, along with an elastic, structured fit for a more tailored look. All items are moisture wicking and machine washable. The line uses three different fabrics: LunAir, 88 percent polyester and 12 percent spandex; SolaSmooth, 73 percent nylon and 27 percent elastane; and StellaForm, 59 percent nylon and 41 percent elastane.

"Everything we use on the line is athletic technical fabric that you would typically find in workout attire, but I've repurposed these fabrics to use in a contemporary womenswear line," Haag tells InnovationMap. "I wanted to create a more foundational capsule clothing collection that women can draw their own inspiration from."

Haag, originally from Houston, studied history and business at Rice University before moving to London to attend the British School of Fashion. Following a few years of work at a London-based fashion PR firm, she returned to Texas. Haag was working a corporate job that required extensive job-site visits.

"I thought, how is there not more stylish women's clothing on the market that is comfortable and functional," says Haag.

The name Cotidié, which means "daily" or "every day," encompasses Haag's desire to create clothing that can be worn at work, for travel, on weekends, and more. Haag was determined to find comfortable professional clothing that held up in Houston's heat and humidity and created Cotidié to bridge the gap between technical performance wear and business attire, introducing a new kind of clothing for stylish women on the go.

Kristina Haag worked a corporate job that required her to run around Houston. She thought of her new fashion line out of wanting stylish clothes conducive to Houston's climate. Lauren Marek/Cotidié

Haag worked for over a year testing different fabrics and designing each piece to blend feminine style with technical performance. Haag works with Sew Pro Production, an apparel manufacturer based in Houston to develop the pieces.

For Cotidié's fall and winter line, which launched in October 2019, Haag adapted the pieces for cooler weather as the temperature shifts.

Haag plans to expand the marketing of Cotidié to a national scale in the next year. The company currently has two employees and has plans to begin fundraising efforts in 2020. The company currently ships internationally.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”